Cyclomics
Our Technologies
At Cyclomics, we are pioneering advancements in molecular diagnostics with our flagship technology, CyclomicsSeq. This cutting-edge liquid biopsy and consensus sequencing platform enables highly sensitive detection of genetic mutations and cancer biomarkers from blood samples. Leveraging our deep expertise in molecular biology and sequencing, we have developed a suite of innovative technologies that offer robust solutions for plasmid sequencing, methylation analysis, and DNA barcoding.
​
In parallel, we have created Epinn, a powerful framework that allows clinicians and researchers to run advanced tumor classification models with ease. Through an intuitive graphical user interface, Epinn streamlines the deployment of complex AI-driven classifiers, reducing analysis time to just 90 minutes from sample to result.
Our commitment to excellence in research and development drives us to continually push the boundaries of what is possible in genomic science, delivering transformative solutions for healthcare and beyond. Find out more about our technology portfolio.
Eager to learn even more?
Let's have a chat!
At Cyclomics, we provide cutting-edge sequencing solutions powered by our proprietary technologies, including CyclomicsSeq and NanoRCS. Our expertise in Nanopore sequencing enables us to deliver high-precision results for a wide range of applications, from early cancer detection to comprehensive genetic analysis. In addition to our specialized assays, we offer tailored Contract Research Organization (CRO) services, allowing you to benefit from our advanced technology and deep industry knowledge. Explore our solutions and discover how Cyclomics can help accelerate your research and development.